Emcure Pharmaceuticals Limited header image

Emcure Pharmaceuticals Limited

544210

Equity

ISIN INE168P01015 / Valor 136422285

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-03)
INR 1,837.10-0.94%

Emcure Pharmaceuticals Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Emcure Pharmaceuticals Limited is a leading Indian multinational pharmaceutical company, incorporated in 1981 and headquartered at Hinjawadi, Pune. The company develops, manufactures and markets a broad portfolio of pharmaceutical formulations (tablets, capsules, injectables and biotherapeutics) across gynaecology, cardiology, dermatology, consumer health, diabetes and other therapeutic areas. Emcure has strong international operations across Europe (particularly Switzerland, through its Zuventus Healthcare subsidiary) and Canada, and in 2025 it partnered with Novo Nordisk to launch a semaglutide brand for obesity in India. The company listed via IPO in July 2024.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

43.5%1Y
%3Y
%5Y

Performance

32.6%1Y
36.7%3Y
36.7%5Y

Volatility

Market cap

3647 M

Market cap (USD)

Daily traded volume (Shares)

1,861

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%CHF 359.40
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%EUR 8.38
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 64.14
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Rubicon Research Limited
Rubicon Research Limited Rubicon Research Limited Valor: 149582844
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.22%INR 1,302.75
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 318.57
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.26%CHF 54.30
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%CHF 9.25
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,646.15
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%GBP 29.76